Growth Metrics

Coeptis Therapeutics Holdings (COEPW) Cash & Current Investments (2021 - 2025)

Coeptis Therapeutics Holdings has reported Cash & Current Investments over the past 5 years, most recently at $6.4 million for Q4 2025.

  • Quarterly results put Cash & Current Investments at $6.4 million for Q4 2025, up 1091.8% from a year ago — trailing twelve months through Dec 2025 was $6.4 million (up 1091.8% YoY), and the annual figure for FY2025 was $6.4 million, up 1091.8%.
  • Cash & Current Investments for Q4 2025 was $6.4 million at Coeptis Therapeutics Holdings, up from $5.3 million in the prior quarter.
  • Over the last five years, Cash & Current Investments for COEPW hit a ceiling of $7.4 million in Q3 2022 and a floor of $532885.0 in Q4 2024.
  • Median Cash & Current Investments over the past 5 years was $2.1 million (2021), compared with a mean of $2.6 million.
  • Biggest five-year swings in Cash & Current Investments: surged 1160.77% in 2022 and later plummeted 80.85% in 2023.
  • Coeptis Therapeutics Holdings' Cash & Current Investments stood at $2.2 million in 2021, then surged by 73.95% to $3.8 million in 2022, then crashed by 61.25% to $1.5 million in 2023, then crashed by 63.73% to $532885.0 in 2024, then skyrocketed by 1091.8% to $6.4 million in 2025.
  • The last three reported values for Cash & Current Investments were $6.4 million (Q4 2025), $5.3 million (Q3 2025), and $3.0 million (Q2 2025) per Business Quant data.